Nurix Therapeutics, Inc. ($NRIX)
Filing Information
| Accession Number | 0001817199-26-000022 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 25, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
86,805
Total Value
$813,352.56
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Jun 25, 2026 | Exercise/Conversion | 13,333 | $7.26 | $96,797.58 | 26,912 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jun 25, 2026 | Exercise/Conversion | 15,602 | $8.72 | $136,049.44 | 42,514 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jun 25, 2026 | Sale | 28,935 | $20.06 | $580,505.54 | 13,579 | Direct | โ | View Details | |
Chief Legal Officer | Employee Stock Option (right to buy) | Derivative | Jun 25, 2026 | Exercise/Conversion | 13,333 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Legal Officer | Employee Stock Option (right to buy) | Derivative | Jun 25, 2026 | Exercise/Conversion | 15,602 | $0.00 | $0.00 | 134,398 | Direct | โ | View Details |